Karen Dybkær

Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition

Steffen Falgreen, Maria Bach Laursen, Julie Støve Bødker, 2014, BMC Bioinformatics.

Unaccounted uncertainty from qPCR efficiency estimates entails uncontrolled false positive rates

Anders Petersen, Steffen Falgreen, Julie Støve Bødker, 2016, BMC Bioinformatics.

NEXT Bioinformatics: Activity Report: 2015 - 2018

Anders Sune Pedersen, Julie Støve Bødker, Hans Erik Johnsen, 2019 .

A reproducible probe level data analysis workflow for Affymetrix Exon arrays using aroma-affymetrix

Julie Støve Bødker, Hans Erik Johnsen, Karen Dybkær, 2012 .

Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives

Julie Støve Bødker, Karen Dybkær, Martin Bøgsted, 2019, Briefings Bioinform..

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis.

Rajen Dinesh Shah, Michael Gaihede, Steffen Falgreen, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models

Steffen Falgreen, Maria Bach Laursen, Hans Erik Johnsen, 2015, BMC Cancer.

Estimation of a common covariance matrix for multiple classes with applications in meta- and discriminant analysis

Karen Dybkær, Martin Bøgsted, Poul Svante Eriksen, 2015 .

Genomic Analyses Reveal Global Functional Alterations That Promote Tumor Growth and Novel Tumor Suppressor Genes in Natural Killer-Cell Malignancies

Karen Dybkær, Javeed Iqbal, Wan L. Lam, 2008 .

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

Ken H. Young, Youli Zu, Govind Bhagat, 2015, Oncotarget.